A Hattori, Y Kuroki, T Katoh, H Takahashi, HQ Shen, Y Suzuki and T Akino
Department of Biochemistry, Sapporo Medical University, School of Medicine, Japan.

Pulmonary alveolar proteinosis (PAP) is a diffuse lung disease of unknown etiology in which the alveoli and terminal bronchioles of the lung fill with large amounts of surfactant-rich lipoproteinaceous materials. Its major pathologic manifestations are a small number of normal tubular myelin structures and an unusual abundance of multilamellated structures. Since surfactant protein A (SP-A) plays an important role in surfactant phospholipid homeostasis, we investigated the structural features of SP-A oligomers (alveolar proteinosis protein, APP) accumulating in the alveoli of individuals with PAP, and examined the abilities of APP to interact with lipids. Analysis of APP by Bio Gel A15m column chromatography revealed that it was composed of two protein peaks, one of which (APP-I) eluted at the position near that of blue dextran whereas the other (APP-II) eluted far behind blue dextran but ahead of thyroglobulin. These populations of APP showed almost identical amino acid compositions. Electron microscopic observations of APP molecules using the rotary shadow technique revealed that APP-II was observed as hexameric particles, presumably consisting mainly of octadecamers whose diameter was approximately 30 nm. The population seen for APP-II was similar to that seen for SP-A from healthy individuals. In contrast, APP-I was observed as multimerized larger aggregates whose diameter appeared to be about 70 to 90 nm. Both APP-I and APP-II retained the abilities to bind dipalmitoylphosphatidylcholine (DPPC). They also induced phospholipid vesicle aggregation in a concentration-dependent manner. The maximal turbidity for light scattering induced by APP-I and APP-II was almost equivalent when analyzed as a function of molar concentration. In vitro reconstitution experiments with porcine surfactant protein B (SP-B) and phospholipids revealed that the multilamellated membranes in structures formed from APP-I consisted of several layers of doubled unit membranes. APP-I failed to form tubular myelin structures. In contrast, APP-II formed well-formed lattice structures seen in tubular myelin. From these data we conclude that there exists an abnormal multimerized form of SP-A oligomer in the alveoli of patients with PAP, and that this unusual subpopulation of SP-A oligomer exhibits abnormal function on phospholipid membrane organization.

This article has been cited by other articles:

				A. A. Beharka, J. E. Crowther, F. X. McCormack, G. M. Denning, J. Lees, E. Tibesar, and L. S. Schlesinger Pulmonary Surfactant Protein A Activates a Phosphatidylinositol 3-Kinase/Calcium Signal Transduction Pathway in Human Macrophages: Participation in the Up-Regulation of Mannose Receptor Activity J. Immunol., August 15, 2005; 175(4): 2227 - 2236. [Abstract] [Full Text] [PDF]

				Q. A. Al-Salmi, J. N. Walter, G. N. Colasurdo, M. M. Sockrider, E. O. Smith, H. Takahashi, and L. L. Fan Serum KL-6 and Surfactant Proteins A and D in Pediatric Interstitial Lung Disease Chest, January 1, 2005; 127(1): 403 - 407. [Abstract] [Full Text] [PDF]

				J. Madsen, I. Tornoe, O. Nielsen, C. Koch, W. Steinhilber, and U. Holmskov Expression and Localization of Lung Surfactant Protein A in Human Tissues Am. J. Respir. Cell Mol. Biol., November 1, 2003; 29(5): 591 - 597. [Abstract] [Full Text]

				J F Seymour, I R Doyle, K Nakata, J J Presneill, O D Schoch, E Hamano, K Uchida, R Fisher, and A R Dunn Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis Thorax, March 1, 2003; 58(3): 252 - 257. [Abstract] [Full Text] [PDF]

				A. A. Beharka, C. D. Gaynor, B. K. Kang, D. R. Voelker, F. X. McCormack, and L. S. Schlesinger Pulmonary Surfactant Protein A Up-Regulates Activity of the Mannose Receptor, a Pattern Recognition Receptor Expressed on Human Macrophages J. Immunol., October 1, 2002; 169(7): 3565 - 3573. [Abstract] [Full Text] [PDF]

				J. F. Seymour and J. J. Presneill Pulmonary Alveolar Proteinosis: Progress in the First 44 Years Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 215 - 235. [Abstract] [Full Text] [PDF]

				M. J. Allen, R. Harbeck, B. Smith, D. R. Voelker, and R. J. Mason Binding of Rat and Human Surfactant Proteins A and D to Aspergillus fumigatus Conidia Infect. Immun., September 1, 1999; 67(9): 4563 - 4569. [Abstract] [Full Text] [PDF]

				T. L. Schagat, M. J. Tino, and J. R. Wright Regulation of Protein Phosphorylation and Pathogen Phagocytosis by Surfactant Protein A Infect. Immun., September 1, 1999; 67(9): 4693 - 4699. [Abstract] [Full Text] [PDF]

				P. Borron, F. X. McCormack, B. M. Elhalwagi, Z. C. Chroneos, J. F. Lewis, S. Zhu, J. R. Wright, V. L. Shepherd, F. Possmayer, K. Inchley, et al. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor Am J Physiol Lung Cell Mol Physiol, October 1, 1998; 275(4): L679 - L686. [Abstract] [Full Text] [PDF]

				E. C. Crouch Collectins and Pulmonary Host Defense Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 177 - 201. [Abstract] [Full Text]

				I. R. DOYLE, K. G. DAVIDSON, H. A. BARR, T. E. NICHOLAS, K. PAYNE, and J. PFITZNER Quantity and Structure of Surfactant Proteins Vary Among Patients with Alveolar Proteinosis Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 658 - 664. [Abstract] [Full Text]